PRECLINICAL DEVELOPMENT OF CNM-AU8 AS A CANDIDATE THERAPEUTIC FOR AMYOTROPHIC LATERAL SCLEROSIS

$0FY2020Department of the ArmyDOD

Clene Nanomedicine, Inc.

Investigators

View source on USAspending →